TECO DIAGNOSTICS- URINE PORPHOBILINOGEN (PBG) TEST KIT
Teco Diagnostics, an industry-leading manufacturer of in-vitro diagnostics and medical devices, recently announced that it has developed a urine rapid test to aid in the primary screening for acute hepatic porphyria (AHP). AHP is a rare and potentially life-threatening genetic disease that often goes misdiagnosed. Because the disease is so rare, physicians will often attempt to rule out other conditions before testing for AHP.
The Teco Diagnostics test is approved as a primary screening tool for AHP. It assists the user by determining the approximate concentrations of porphobilinogen (PBG) in urine within approximately 30 minutes. As this is a primary screening method, every positive result should be confirmed by quantitative estimation.
The rapid turnaround time could potentially help improve patient management and reduce the number of patients lost to follow-up. “It can take an average of 15 years to get a diagnosis for this disease, which from a patient’s perspective, can equate to a lot of unnecessary suffering,” said Teco leader Aquil Merchant. “Teco realized that there is an unmet medical need for such a test to be in the healthcare sector after speaking with key opinion leaders and experts in porphyrias. This test has been requested for by the FDA as well”– Aquil. The test is currently available For Professional Use Only and can be purchased directly from Teco Diagnostics.
United Porphyrias held an educational training session for the experts of the Porphyrias Consortium. Your porphyria specialists are now trained in the ordering and use of this new tool.
Please contact UPA for information on this new screening tool and other diagnostic testing. We will connect you or your physician with a knowledgeable doctor.
Thank you to Alnylam Pharmaceuticals for funding Teco Diagnostics to develop this product!
To watch a demo of the rapid urine screen, click below.
|